INTRA-CELLULAR THERAPIES INC

CUSIP: 46116X101 Class: Common Stock

SUVRETTA CAPITAL MANAGEMENT, LLC's Holding History (CIK: 0001569064)

Note: Option positions (PUT/CALL) are excluded.

Q1 2025
Shares 700,904 Value ($000) $92,463 Avg Close Range
Q4 2024
Shares 1,439,026 Value ($000) $120,187 Avg Close Range
Q3 2024
Shares 1,439,026 Value ($000) $105,294 Avg Close Range
Q2 2024
Shares 1,565,996 Value ($000) $107,255 Avg Close Range
Q1 2024
Shares 959,198 Value ($000) $66,377 Avg Close Range
Q4 2023
Shares 1,165,948 Value ($000) $83,505 Avg Close Range
Q3 2023
Shares 1,369,849 Value ($000) $71,355 Avg Close Range
Q2 2023
Shares 1,198,971 Value ($000) $75,919 Avg Close Range
Q1 2023
Shares 1,198,971 Value ($000) $64,924 Avg Close Range
Q4 2022
Shares 1,036,948 Value ($000) $54,875 Avg Close Range
Q3 2022
Shares 851,958 Value ($000) $39,642 Avg Close Range
Q2 2022
Shares 1,338,700 Value ($000) $76,413 Avg Close Range
Q1 2022
Shares 1,531,923 Value ($000) $93,738 Avg Close Range
Q4 2021
Shares 1,251,946 Value ($000) $65,527 Avg Close Range
Q3 2021
Shares 1,251,946 Value ($000) $46,673 Avg Close Range
Q2 2021
Shares 1,038,770 Value ($000) $42,403 Avg Close Range
Q1 2021
Shares 1,038,770 Value ($000) $35,245 Avg Close Range
Q4 2020
Shares 905,970 Value ($000) $28,810 Avg Close Range
Q3 2020
Shares 492,270 Value ($000) $12,632 Avg Close Range